MedTrace Logo

Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial

NCT04405258 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2024-06-14

No results posted yet for this study

Summary

The purpose for this study is to determine whether left posterior wall isolation (PWI) in addition to pulmonary vein isolation (PVI) is effective as ablation strategy for persistent atrial fibrillation (AF).

Conditions

  • Persistent Atrial Fibrillation
  • Catheter Ablation
  • Pulmonary Vein Isolation
  • Posterior Wall Isolation

Interventions

PROCEDURE

Pulmonary vein isolation

Pulmonary vein isolation, superior vena cava isolation, and cavotricuspid isthmus ablation

PROCEDURE

Left posterior wall isolation

Pulmonary vein isolation, superior vena cava isolation, cavotricuspid isthmus ablation, and left posterior wall isolation

Sponsors & Collaborators

  • Institute for Clinical Effectiveness, Japan

    lead OTHER

Principal Investigators

  • Keisuke Okawa, MD · Kagawa Prefectural Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-08
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405258 on ClinicalTrials.gov